Covid-19 roundup: Pfiz­er/BioN­Tech vac­cine on verge of EU au­tho­riza­tion; Cure­Vac launch­es PhI­II tri­al in health­care work­ers

It looks like the Eu­ro­pean Union may be get­ting the Pfiz­er/BioN­Tech vac­cine in time for the new year.

The EMA’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.